ECs from patients with PAH exhibit altered BMP9 and IL-6 responses compared with control cells.9 Prolonged BMP9 exposure in PAH MVECs induces EndMT-like changes, including VE-cadherin loss and increased SM22α expression. The gene discussed is CDH5; the disease is pulmonary arterial hypertension.